Header Logo

Connection

Yuki Kageyama to Prognosis

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Prognosis.
Yuki Kageyama
Connection Strength
0.381
Prognosis
  1. STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
    View in: PubMed
    Score: 0.119
  2. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Res. 2022 Feb; 42(2):1131-1136.
    View in: PubMed
    Score: 0.102
  3. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021 Mar; 70(3):657-665.
    View in: PubMed
    Score: 0.023
  4. Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma. Int J Urol. 2020 Aug; 27(8):657-662.
    View in: PubMed
    Score: 0.023
  5. [Treatment results of radical nephrectomy for relatively confined small renal cell carcinoma--translumbar versus transabdominal approach]. Nihon Hinyokika Gakkai Zasshi. 1994 Apr; 85(4):599-603.
    View in: PubMed
    Score: 0.015
  6. Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology. 2011 Apr; 77(4):842-7.
    View in: PubMed
    Score: 0.012
  7. [Result of treatment for advanced germ cell tumor in the last decade]. Nihon Hinyokika Gakkai Zasshi. 2010 Mar; 101(3):539-46.
    View in: PubMed
    Score: 0.011
  8. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009 Jul; 104(2):189-94.
    View in: PubMed
    Score: 0.010
  9. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol. 2008 Aug; 180(2):618-21; discussion 621.
    View in: PubMed
    Score: 0.010
  10. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008 Apr; 101(8):978-81.
    View in: PubMed
    Score: 0.010
  11. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007 Aug; 100(2):269-73.
    View in: PubMed
    Score: 0.009
  12. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU Int. 2006 Jun; 97(6):1322-6.
    View in: PubMed
    Score: 0.009
  13. Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol. 2004 Mar; 171(3):1080-4.
    View in: PubMed
    Score: 0.007
  14. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003 Nov 15; 9(15):5501-7.
    View in: PubMed
    Score: 0.007
  15. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients. Anticancer Res. 2003 Jul-Aug; 23(4):3441-6.
    View in: PubMed
    Score: 0.007
  16. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998; 33(5):464-8.
    View in: PubMed
    Score: 0.005
  17. [The clinical study of 23 cases in patients with bladder cancer over 85 years old]. Hinyokika Kiyo. 1989 Jul; 35(7):1141-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.